[Optimizing the care management pathway of patients with ischemia and non-obstructive coronary arteries]

Fabrizio Oliva1, Giuseppe Boriani2, Paolo Calabrò3

  • 1Cardiologia 1-Emodinamica, ASST Grande Ospedale Metropolitano Niguarda, Milano.

Giornale Italiano Di Cardiologia (2006)
|April 19, 2024
PubMed

Insights

Ischemia with non-obstructive coronary arteries (INOCA) is a common condition often underdiagnosed. This initiative aimed to standardize INOCA diagnosis and management, improving patient care and outcomes.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Vascular Biology

Context:

  • Ischemia with non-obstructive coronary arteries (INOCA) presents with anginal symptoms and ischemia but no obstructive coronary artery disease.
  • Coronary microvascular dysfunction and vasospasm are key underlying mechanisms in INOCA.
  • INOCA patients experience recurrent symptoms, functional limitations, reduced quality of life, and increased cardiovascular events.

Purpose:

  • To disseminate evidence on INOCA as a distinct clinical entity.
  • To develop uniform and shared management pathways for INOCA patients.
  • To improve the diagnosis and management of INOCA across various clinical settings.

Summary:

  • A 2022 clinical practice improvement initiative involved 30 cardiology units nationwide.
  • The initiative focused on standardizing the diagnosis and management of INOCA.
  • Outcomes of this multidisciplinary effort are presented to guide clinical practice.

Impact:

  • Addresses the underdiagnosis of INOCA due to lack of awareness and standardized diagnostic tools.
  • Aims to improve the quality of life and reduce cardiovascular events in INOCA patients.
  • Promotes consistent and effective management strategies for INOCA across different healthcare settings.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
570
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
498
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
3.8K
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
579
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.5K